BREEDLOVE ROBERT CHARLES (Principal Accounting Officer) sold 1.1% of their position (524.00 shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $7.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/5/2025ACC: 0001193125-25-267057
Officer· Principal Accounting Officer
Since Feb 2026
-524.00
Net shares
Net seller
$7.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
524.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−524.00
Price / share
$13.51
Trade value
$7.08K
% of position
1.1%
11/3/2025
47.93K→47.41K
Total
Net shares
−524.00
Net value
-$7.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/3/2025 | S · Sale | −524.00 | $13.51 | $7.08K | 1.1% | 47.93K | 47.41K |
| Total | −524.00 | -$7.08K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.95K
Total
6.95K indirect6.95K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.95K | Indirect |
| Total | 6.95K | 6.95K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported